Natco Pharma shares jump 5% as company files for generic cancer drug approval with USFDA

Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity.

More To Explore